MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-19-0225907
Narix Pharmaceuticals Private Limited
Narix Pharmaceuticals Private Limited - agriculture in Mumbai, Maharashtra, India. Directors, charges & compliance details.
Revenue · FY 2025
₹1.26 Cr
▲ 61% YoY
Net loss · FY 2025
₹5.54 Lakh
Net margin -4.4%
EBITDA · FY 2025
-₹5.25 Lakh
EBITDA margin -4.2%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
4 yrs
Est. 2022
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Narix Pharmaceuticals Private Limited
Data last updated:
Narix Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the agriculture raw material segment of the agriculture sector. It was incorporated on 16 November 2022.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51220MH2022PTC393629. Its GSTIN is 27AAICN5916B1ZK (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Naman Shripal Katariya and Shripal Lalchand Katariya.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.26 Cr, a growth of 61% compared to the previous year. For the same year it recorded a net loss of ₹5.54 Lakh (net margin -4.4%) and EBITDA of -₹5.25 Lakh (EBITDA margin -4.2%).
Narix Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0225907). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U51220MH2022PTC393629
Registration Number 393629
Incorporation Date 16 November 2022
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MH-19-0225907
Recognitions & Rankings of Narix Pharmaceuticals
Contact details
Narix Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra.
- Registered Address404 4th Floor Plot Cs No. 918 To 921 And 925, East Bay Bayvue Dr. M B Velkar Marg Kalbadevi, Mumbai, Maharashtra, India – 400002
- IndustryAgriculture, Agriculture Raw Material, Animal Rearing, Wholesale
Comprehensive company report
Narix Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Narix Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Narix Pharmaceuticals Private Limited, buy the company report.
Financials of Narix Pharmaceuticals Private Limited
FY 2025 filings availableNarix Pharmaceuticals Private Limited reported revenue of ₹1.26 Cr (up 61% YoY) for FY 2025.
Revenue · FY 2025
₹1.26 Cr ▲ 61%
Net loss · FY 2025
₹5.54 Lakh margin -4.4%
EBITDA · FY 2025
-₹5.25 Lakh margin -4.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 61%
EBITDA CAGR growth
1 year
▲ 9%
Revenue rose 61% in the latest year. EBITDA rose 9% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹5.25 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹5.54 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -4.2% | ||
| Net Profit Margin | -4.4% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Narix Pharmaceuticals Private Limited, buy the company report.
Board of directors of Narix Pharmaceuticals Private Limited
Narix Pharmaceuticals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Naman Shripal Katariya Also directs: O2 Global Ventures LLP | Director | 16 Nov 2022 | 3 Years 11 Months | Current |
| Shripal Lalchand Katariya Also directs: O2 Global Ventures LLP | Director | 16 Nov 2022 | 3 Years 11 Months | Current |
Peer comparison
Narix Pharmaceuticals Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Avis Biotec Private Limited | ₹1.27 Cr (FY 2024) | -14.0% | Jaipur, Rajasthan, India | |||
| Naturegift Wellness Private Limited | ₹1.26 Cr (FY 2023) | -12.0% | Sancoale, Goa, India | |||
| Sakya Sales and Solutions Private Limited | ₹1.26 Cr (FY 2024) | 1293.0% | Indore, Madhya Pradesh, India | |||
| Narix Pharmaceuticals Private Limitedthis company | ₹1.26 Cr (FY 2025) | -₹5.54 Lakh | -4.4% | 61.0% | Mumbai, Maharashtra, India | |
| Douglas Pharmaceuticals Private Limited | ₹1.26 Cr (FY 2025) | -18.0% | Hyderabad, Telangana, India | |||
| Sarvee Integra Private Limited | ₹1.26 Cr (FY 2025) | 29.0% | Chennai, Tamil Nadu, India | |||
| Macron Biotech Private Limited | ₹1.26 Cr (FY 2017) | 16.0% | Varanasi, Uttar Pradesh, India |
To see the full peer comparison of Narix Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Narix Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Narix Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Narix Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAICN5916B1ZK | Maharashtra | Active | 02 Feb 2023 |
To see the full GST registrations and return filing status of Narix Pharmaceuticals Private Limited, buy the company report.
Recent activity
Narix Pharmaceuticals Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Naman Shripal Katariya was appointed as Director on 16 Nov 2022.
AGM
Narix Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Narix Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Appointed
Naman Shripal Katariya was appointed as Director.
Appointed
Shripal Lalchand Katariya was appointed as Director.
Incorporation
16 Nov 2022
Narix Pharmaceuticals Private Limited was registered on 16 Nov 2022 with Roc Mumbai & aged 3 years 11 months as per MCA records.
Frequently asked questions
Narix Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in agriculture raw material, within the agriculture industry. It was incorporated on 16 November 2022 (4+ years old) and is registered under CIN U51220MH2022PTC393629.
Narix Pharmaceuticals has 2 current directors:
- Naman Shripal Katariya - Director
- Shripal Lalchand Katariya - Director
The latest financial statements of Narix Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The GSTIN of Narix Pharmaceuticals is 27AAICN5916B1ZK, registered in Maharashtra.
The CIN (Corporate Identification Number) of Narix Pharmaceuticals is U51220MH2022PTC393629. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Narix Pharmaceuticals was incorporated on 16 November 2022, making it 4+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Narix Pharmaceuticals by revenue are Avis Biotec Private Limited, Naturegift Wellness Private Limited, Sakya Sales and Solutions Private Limited, Douglas Pharmaceuticals Private Limited, Sarvee Integra Private Limited and 1 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Naman Shripal Katariya was appointed as Director on 16 Nov 2022. Shripal Lalchand Katariya was appointed as Director on 16 Nov 2022.
Yes, Narix Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-19-0225907).
The registered office of Narix Pharmaceuticals is at 404 4th Floor Plot Cs No. 918 To 921 And 925, East Bay Bayvue Dr. M B Velkar Marg Kalbadevi, Mumbai, Maharashtra, India – 400002.
Narix Pharmaceuticals operates in the agriculture industry, in the agriculture raw material segment.